Boris Bastian, MD, PhD

Expanding the genetic spectrum of pigmentation. (18721233)

Bastian BC, Pinkel D PMID: 18721233

Lack of somatic alterations of MC1R in primary melanoma. (18761657)

Kim RD, Curtin JA, Bastian BC PMID: 18761657

Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas. (17488338)

Murata H, Ashida A, Takata M, Yamaura M, Bastian BC, Saida T PMID: 17488338

Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: A matrix-based CGH approach. (17044049)

Thorns C, Bastian B, Pinkel D, Roydasgupta R, Fridlyand J, Merz H, Krokowski M, Bernd HW, Feller AC PMID: 17044049

In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling. (17018604)

Dumaz N, Hayward R, Martin J, Ogilvie L, Hedley D, Curtin JA, Bastian BC, Springer C, Marais R PMID: 17018604

Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. (16964246)

Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR, Pointer JN, Gruber SB, Su LD, Nikiforov MA, Kaufman RJ, Bastian BC, Soengas MS PMID: 16964246

Somatic activation of KIT in distinct subtypes of melanoma. (16908931)

Curtin JA, Busam K, Pinkel D, Bastian BC PMID: 16908931

Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. (16888631)

Bauer J, Curtin JA, Pinkel D, Bastian BC PMID: 16888631

MC1R germline variants confer risk for BRAF-mutant melanoma. (16809487)

Landi MT, Bauer J, Pfeiffer RM, Elder DE, Hulley B, Minghetti P, Calista D, Kanetsky PA, Pinkel D, Bastian BC PMID: 16809487

PI3-kinase subunits are infrequent somatic targets in melanoma. (16614723)

Curtin JA, Stark MS, Pinkel D, Hayward NK, Bastian BC PMID: 16614723